Farther Finance Advisors’s VistaGen Therapeutics VTGN Stock Holding History

Farther Finance Advisors’s Portfolio VTGN Stock Details VTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.62K	Hold	15,000	–	–	﹤0.01%	5052
2026 Q2	$3.39K	Buy	+15,000	New	+$9.05K	﹤0.01%	4977
2024 Q4	–	Sell	-81	Closed	-$244	–	4159
2024 Q3	$244	Hold	81	–	–	﹤0.01%	3604
2024 Q2	$289	Hold	81	–	–	﹤0.01%	3409
2024 Q1	$437	Buy	+81	New	+$389	﹤0.01%	3059

Farther Finance Advisors's VTGN Position: Q3 2026 in Review

Farther Finance Advisors held its VistaGen Therapeutics (VTGN) position steady in Q3 2026 at 15,000 shares worth $4.62K. The position accounts for ﹤0.01% of the portfolio, ranked #5052.

Farther Finance Advisors first reported a position in VTGN in Q1 2024 and has held it in 5 quarters since. 1 fund tracked by Wall St. Rank holds VTGN as of Q3 2026.

Farther Finance Advisors held 15,000 shares of VistaGen Therapeutics worth $4.62K as of Q3 2026.
Farther Finance Advisors left its VistaGen Therapeutics share count unchanged in Q3 2026.
VistaGen Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5052 holding.
Farther Finance Advisors first reported a position in VistaGen Therapeutics in Q1 2024 and has held it in 5 quarters since.
1 fund tracked by Wall St. Rank held VistaGen Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.